Fierce Biotech

Subscribe to Fierce Biotech feed
Updated: 4 hours 42 min ago

Exo officially enters handheld ultrasound race with launch of AI-powered Iris system

Fri, 09/29/2023 - 09:15
Exo officially enters handheld ultrasound race with launch of AI-powered Iris system apark Fri, 09/29/2023 - 12:15

FDA publishes proposal to increase regulatory oversight of lab-developed tests

Fri, 09/29/2023 - 08:23
FDA publishes proposal to increase regulatory oversight of lab-developed tests chale Fri, 09/29/2023 - 11:23

ModeX nets up to $168M in BARDA bucks to develop therapies for viral infections

Fri, 09/29/2023 - 07:08
ModeX nets up to $168M in BARDA bucks to develop therapies for viral infections mbayer Fri, 09/29/2023 - 10:08

Abbott analysis finds FreeStyle Libre CGM and GLP-1 drug adherence rise when used together

Fri, 09/29/2023 - 07:03
Abbott analysis finds FreeStyle Libre CGM and GLP-1 drug adherence rise when used together apark Fri, 09/29/2023 - 10:03

Siemens Healthineers debuts 5-second 3D mammogram machine, new mobile MRI

Fri, 09/29/2023 - 06:56
Siemens Healthineers debuts 5-second 3D mammogram machine, new mobile MRI chale Fri, 09/29/2023 - 09:56

Adlai, building on the ashes of Novartis' failure, raises $57.5M IPO to run phase 3 cancer trial

Fri, 09/29/2023 - 06:24
Adlai, building on the ashes of Novartis' failure, raises $57.5M IPO to run phase 3 cancer trial ntaylor Fri, 09/29/2023 - 09:24

PTC deepens layoffs as DMD drug faces loss of authorization across Europe

Fri, 09/29/2023 - 03:07
PTC deepens layoffs as DMD drug faces loss of authorization across Europe jwaldron Fri, 09/29/2023 - 06:07

Structure posts early oral obesity findings but delays larger readout after data collection mistake

Fri, 09/29/2023 - 01:12
Structure posts early oral obesity findings but delays larger readout after data collection mistake ntaylor Fri, 09/29/2023 - 04:12

Chutes & Ladders—Madrigal COO exits 2 weeks after new CEO Bill Sibold starts

Thu, 09/28/2023 - 13:09
Chutes & Ladders—Madrigal COO exits 2 weeks after new CEO Bill Sibold starts mbayer Thu, 09/28/2023 - 16:09

Revvity rolls out base editing reagents to increase access to preclinical DNA editing tech

Thu, 09/28/2023 - 10:16
Revvity rolls out base editing reagents to increase access to preclinical DNA editing tech apark Thu, 09/28/2023 - 13:16

U.S. cancer report details how diagnoses dropped during the COVID-19 pandemic

Thu, 09/28/2023 - 09:28
U.S. cancer report details how diagnoses dropped during the COVID-19 pandemic chale Thu, 09/28/2023 - 12:28

Karuna’s KarXT reaches FDA with hopes for first new schizophrenia drug mechanism in decades

Thu, 09/28/2023 - 07:31
Karuna’s KarXT reaches FDA with hopes for first new schizophrenia drug mechanism in decades mbayer Thu, 09/28/2023 - 10:31

Harbinger Health foreshadows launch of blood-based cancer screening platform with $140M VC round

Thu, 09/28/2023 - 07:14
Harbinger Health foreshadows launch of blood-based cancer screening platform with $140M VC round apark Thu, 09/28/2023 - 10:14

Yamaha revs up new US antibody profiling business Tuning Fork Bio

Thu, 09/28/2023 - 07:07
Yamaha revs up new US antibody profiling business Tuning Fork Bio chale Thu, 09/28/2023 - 10:07

Merck KGaA goes again in AI, expanding Quris toxicity prediction pact days after inking 2 deals

Thu, 09/28/2023 - 06:24
Merck KGaA goes again in AI, expanding Quris toxicity prediction pact days after inking 2 deals ntaylor Thu, 09/28/2023 - 09:24

Bionomics’ midphase PTSD trial hits primary endpoint, tripling its battered share price

Thu, 09/28/2023 - 04:09
Bionomics’ midphase PTSD trial hits primary endpoint, tripling its battered share price ntaylor Thu, 09/28/2023 - 07:09

Gritstone in line for $433M in BARDA funds to push mRNA COVID-19 shot into large-scale trial

Thu, 09/28/2023 - 02:55
Gritstone in line for $433M in BARDA funds to push mRNA COVID-19 shot into large-scale trial jwaldron Thu, 09/28/2023 - 05:55

Emmes calls in telehealth capabilities to expand eClinical platform

Wed, 09/27/2023 - 21:53
Emmes calls in telehealth capabilities to expand eClinical platform jkeenan Thu, 09/28/2023 - 00:53

Clario partners with CellCarta to streamline trial tissue, sample handling

Wed, 09/27/2023 - 21:26
Clario partners with CellCarta to streamline trial tissue, sample handling jkeenan Thu, 09/28/2023 - 00:26

To help drugs withstand the 'white hot heat' of human trials, scientists model the preclinic after the clinic

Wed, 09/27/2023 - 14:22
To help drugs withstand the 'white hot heat' of human trials, scientists model the preclinic after the clinic hfloersh Wed, 09/27/2023 - 17:22